CASR and neonatal severe primary hyperparathyroidism: Inactivating CaSR mutations develop hypocalciuric hypercalcemia and neonatal hyperparathyroidism, while activating CaSR gene mutations are associated with autosomal dominant hypocalcemia with Bartter syndrome type V[8].